{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:50:38Z","timestamp":1792065038305,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":279,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NAM Journal"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.namjnl.2026.100142","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:58:17Z","timestamp":1791442697000},"page":"100142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Static or microfluidic? A comparative pilot study of an in vivo-in vitro validated human iPSC-derived blood-brain barrier model for neurotoxicity hazard assessment"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1986-4576","authenticated-orcid":false,"given":"Paul","family":"Kurtenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2503-5152","authenticated-orcid":false,"given":"Maria","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Thevis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-6078","authenticated-orcid":false,"given":"Marc","family":"Lamsh\u00f6ft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.namjnl.2026.100142_bib0001","series-title":"Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches","first-page":"3","article-title":"Anatomy and physiology of the blood-brain barriers","author":"Abbott","year":"2022"},{"key":"10.1016\/j.namjnl.2026.100142_bib0002","series-title":"Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches","first-page":"211","article-title":"In vitro models of CNS barriers","author":"Abbott","year":"2022"},{"key":"10.1016\/j.namjnl.2026.100142_bib0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejpb.2022.02.017","article-title":"Re-evaluation of the hCMEC\/D3 based in vitro BBB model for ABC transporter studies","volume":"173","author":"Balzer","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.namjnl.2026.100142_bib0004","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/jcbfm.2015.19","article-title":"Approaching complete inhibition of P-glycoprotein at the human blood\u2013brain barrier: an (R)-[11C] verapamil PET study","volume":"35","author":"Bauer","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.namjnl.2026.100142_bib0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1528-1167.2006.00960.x","article-title":"Development of a humanized in vitro blood\u2013brain barrier model to screen for brain penetration of antiepileptic drugs","volume":"48","author":"Cucullo","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.namjnl.2026.100142_bib0006","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/stem.2908","article-title":"Barrier properties and transcriptome expression in human iPSC-derived models of the blood\u2013brain barrier","volume":"36","author":"Delsing","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.namjnl.2026.100142_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103533","article-title":"Models of the blood-brain barrier using iPSC-derived cells","volume":"107","author":"Delsing","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.namjnl.2026.100142_bib0008","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1177\/2472555220923332","article-title":"Recommended guidelines for developing, qualifying, and implementing complex in vitro models (CIVMs) for drug discovery","volume":"25","author":"Ekert","year":"2020","journal-title":"Slas Discov.: Adv. Sci. Drug Discov."},{"key":"10.1016\/j.namjnl.2026.100142_bib0009","article-title":"Development of a roadmap for action on new approach methodologies in risk assessment","volume":"19","author":"Escher","year":"2022","journal-title":"EFSA Support. Publ."},{"key":"10.1016\/j.namjnl.2026.100142_bib0011","series-title":"Roadmap Towards Phasing out Animal Testing for Chemical Safety Assessments","first-page":"3497","year":"2026"},{"key":"10.1016\/j.namjnl.2026.100142_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121525","article-title":"Human iPSC-derived brain endothelial microvessels in a multi-well format enable permeability screens of anti-inflammatory drugs","volume":"286","author":"Fengler","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.namjnl.2026.100142_bib0013","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/jpet.120.000158","article-title":"Calculation of an apical efflux ratio from P-glycoprotein (P-gp) in vitro transport experiments shows an improved correlation with in vivo cerebrospinal fluid measurements in rats: impact on P-gp screening and compound optimization","volume":"376","author":"Fischer","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.namjnl.2026.100142_bib0014","first-page":"183","article-title":"A path forward advancing microphysiological systems","volume":"42","author":"Hartung","year":"2025","journal-title":"ALTEX: Altern. Anim. Exp."},{"key":"10.1016\/j.namjnl.2026.100142_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1535112","article-title":"Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment","volume":"7","author":"Illa","year":"2025","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.namjnl.2026.100142_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-85019-6","article-title":"Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials","volume":"11","author":"Jablonska","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.namjnl.2026.100142_bib0017","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.3390\/cells11203295","article-title":"A human stem cell-derived brain-liver chip for assessing blood-brain-barrier permeation of pharmaceutical drugs","volume":"11","author":"Koenig","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.namjnl.2026.100142_bib0018","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00259-009-1332-5","article-title":"Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C] verapamil PET","volume":"37","author":"Kuntner","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.namjnl.2026.100142_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2026.100092","article-title":"From in vitro permeability to in vivo brain exposure: continued validation of a human iPSC-derived blood-brain barrier model with pesticides and stimulants","volume":"2","author":"Kurtenbach","year":"2026","journal-title":"NAM J."},{"key":"10.1016\/j.namjnl.2026.100142_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2025.100039","article-title":"A cryopreserved and in vivo-in vitro validated human induced pluripotent stem cell blood-brain barrier model for reliable neurotoxicity assessment","volume":"1","author":"Kurtenbach","year":"2025","journal-title":"NAM J."},{"key":"10.1016\/j.namjnl.2026.100142_bib0021","article-title":"Proof-of-concept study of drug brain permeability between in vivo human brain and an in vitro iPSCs-human blood-brain barrier model","volume":"9","author":"Le Roux","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.namjnl.2026.100142_bib0022","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s00204-017-2045-3","article-title":"Adverse outcome pathways: opportunities, limitations and open questions","volume":"91","author":"Leist","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.namjnl.2026.100142_bib0023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yrtph.2018.06.003","article-title":"A comparison of in vitro cytotoxicity assays in medical device regulatory studies","volume":"97","author":"Liu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.namjnl.2026.100142_bib0024","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/bios12100839","article-title":"Metabolic assessment of human induced pluripotent stem cells-derived astrocytes and fetal primary astrocytes: lactate and glucose turnover","volume":"12","author":"Matthiesen","year":"2022","journal-title":"Biosens. (Basel)"},{"key":"10.1016\/j.namjnl.2026.100142_bib0025","series-title":"Test Guideline No. 455 Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists","year":"2021"},{"key":"10.1016\/j.namjnl.2026.100142_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105904","article-title":"A call to action: advancing new approach methodologies (NAMs) in regulatory toxicology through a unified framework for validation and acceptance","volume":"162","author":"Ouedraogo","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.namjnl.2026.100142_bib0027","first-page":"185","article-title":"Requirements for the validation of analytical methods","volume":"76","author":"Peters","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"10.1016\/j.namjnl.2026.100142_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coche.2020.05.006","article-title":"Advances and opportunities for hiPSC-derived models of the blood-brain barrier","volume":"30","author":"Seo","year":"2020","journal-title":"Curr Opin Chem Eng"},{"key":"10.1016\/j.namjnl.2026.100142_bib0029","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymeth.2015.10.016","article-title":"Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells","volume":"101","author":"Stebbins","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.namjnl.2026.100142_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2024.1359507","article-title":"New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project","volume":"6","author":"Tal","year":"2024","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.namjnl.2026.100142_bib0031","first-page":"615","article-title":"New approach methods (NAMs) supporting read-across: two neurotoxicity AOP-based IATA case studies","volume":"38","author":"Van der Stel","year":"2021","journal-title":"ALTEX: Altern. Anim. Exp."},{"key":"10.1016\/j.namjnl.2026.100142_bib0032","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/mi12060685","article-title":"Transendothelial electrical resistance measurement across the blood\u2013brain barrier: a critical review of methods","volume":"12","author":"Vigh","year":"2021","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.namjnl.2026.100142_bib0033","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bit.26045","article-title":"Microfluidic blood\u2013brain barrier model provides in vivo-like barrier properties for drug permeability screening","volume":"114","author":"Wang","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.namjnl.2026.100142_bib0034","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.7150\/thno.63195","article-title":"Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier","volume":"11","author":"Yan","year":"2021","journal-title":"Theranostics"}],"container-title":["NAM Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050620426000679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050620426000679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:02:03Z","timestamp":1792062123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050620426000679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"alternative-id":["S3050620426000679"],"URL":"https:\/\/doi.org\/10.1016\/j.namjnl.2026.100142","relation":{},"ISSN":["3050-6204"],"issn-type":[{"value":"3050-6204","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Static or microfluidic? A comparative pilot study of an in vivo-in vitro validated human iPSC-derived blood-brain barrier model for neurotoxicity hazard assessment","name":"articletitle","label":"Article Title"},{"value":"NAM Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.namjnl.2026.100142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100142"}}